Literature DB >> 20386986

Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries.

Aditi I Dagli1, Philip J Lee, Catherine E Correia, Christina Rodriguez, Kaustav Bhattacharya, Linda Steinkrauss, Charles A Stanley, David A Weinstein.   

Abstract

Patients with type Ia glycogen storage disease (GSD) have been surviving well into adulthood since continuous glucose therapy was introduced in the 1970s, and there have been many documented successful pregnancies in women with this condition. Historically, few individuals with type Ib GSD, however, survived into adulthood prior to the introduction of granulocyte colony stimulating factor (G-CSF) in the late 1980s. There are no previously published reports of pregnancies in GSD type Ib. In this case report we describe the course and management of five successful pregnancies in three patients with GSD type Ib. Patient 1 experienced an increase in glucose requirement in all three of her pregnancies, starting from the second trimester onwards. There were no major complications related to neutropenia except for oral ulcers. The infants did well, except for respiratory distress in two of them at birth. Patient 2 used cornstarch to maintain euglycemia, but precise dosing was not part of her regimen, and, hence, an increase in metabolic demands was difficult to demonstrate. She developed a renal calculus and urinary tract infection during her pregnancy and had chronic iron deficiency anemia but no neutropenia. The neonate did well after delivery. Patient 3 had poor follow-up during pregnancy. Increasing glucose requirements, worsening lipid profile, neutropenia associated with multiple infections, and anemia were noted. The newborn infant did well after delivery. In addition to the case reports, the challenges of the usage of G-CSF, the treatment of enterocolitis, and comparisons with the management of GSD Ia are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386986      PMCID: PMC3800278          DOI: 10.1007/s10545-010-9054-1

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  40 in total

Review 1.  Glycogen storage diseases.

Authors:  Joseph I Wolfsdorf; David A Weinstein
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Adalimumab use in pregnancy.

Authors:  L Vesga; J P Terdiman; U Mahadevan
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Successful use of adalimumab (Humira) for Crohn's disease in pregnancy.

Authors:  Daniel S Mishkin; William Van Deinse; James M Becker; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2006-08       Impact factor: 5.325

4.  Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study.

Authors:  Aurora Bortoli; Simone Saibeni; Maria Tatarella; Alberto Prada; Luigi Beretta; Roberta Rivolta; Patrizia Politi; Paolo Ravelli; Gianni Imperiali; Enrico Colombo; Angelo Pera; Marco Daperno; Marino Carnovali; Roberto de Franchis; Maurizio Vecchi
Journal:  J Gastroenterol Hepatol       Date:  2007-04       Impact factor: 4.029

5.  Crohn's disease and pregnancy.

Authors:  K Woolfson; Z Cohen; R S McLeod
Journal:  Dis Colon Rectum       Date:  1990-10       Impact factor: 4.585

6.  Managing passively acquired autoimmune neonatal neutropenia: a case study.

Authors:  Y L Fung; L A Pitcher; K Taylor; R M Minchinton
Journal:  Transfus Med       Date:  2005-04       Impact factor: 2.019

Review 7.  Pregnancy and breastfeeding in patients with Crohn's disease.

Authors:  Christian Mottet; Pascal Juillerat; Valérie Pittet; Jean-Jacques Gonvers; Florian Froehlich; John-Paul Vader; Pierre Michetti; Christian Felley
Journal:  Digestion       Date:  2008-02-07       Impact factor: 3.216

8.  Adalimumab for the treatment of Crohn-like colitis and enteritis in glycogen storage disease type Ib.

Authors:  M K Davis; P A Rufo; S F Polyak; D A Weinstein
Journal:  J Inherit Metab Dis       Date:  2008-01-05       Impact factor: 4.982

9.  Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.

Authors:  Stephen B Hanauer; William J Sandborn; Paul Rutgeerts; Richard N Fedorak; Milan Lukas; Donald MacIntosh; Remo Panaccione; Douglas Wolf; Paul Pollack
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

10.  Pregnancy in Crohn's disease.

Authors:  O H Nielsen; B Andreasson; S Bondesen; O Jacobsen; S Jarnum
Journal:  Scand J Gastroenterol       Date:  1984-09       Impact factor: 2.423

View more
  5 in total

1.  Pregnancy and its management in women with GSD type III - a single centre experience.

Authors:  Radha Ramachandran; Yehani Wedatilake; Caroline Coats; Fiona Walker; Perry Elliott; Philip J Lee; Robin H Lachmann; Elaine Murphy
Journal:  J Inherit Metab Dis       Date:  2011-09-07       Impact factor: 4.982

2.  Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study.

Authors:  Annalisa Sechi; Laura Deroma; Annunziata Lapolla; Sabrina Paci; Daniela Melis; Alberto Burlina; Francesca Carubbi; Miriam Rigoldi; Maja Di Rocco
Journal:  J Inherit Metab Dis       Date:  2012-05-05       Impact factor: 4.982

Review 3.  Glucose-6-phosphatase deficiency.

Authors:  Roseline Froissart; Monique Piraud; Alix Mollet Boudjemline; Christine Vianey-Saban; François Petit; Aurélie Hubert-Buron; Pascale Trioche Eberschweiler; Vincent Gajdos; Philippe Labrune
Journal:  Orphanet J Rare Dis       Date:  2011-05-20       Impact factor: 4.123

Review 4.  Impact of pregnancy on inborn errors of metabolism.

Authors:  Gisela Wilcox
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

5.  Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib.

Authors:  Sarah Catharina Grünert; Stefanie Rosenbaum-Fabian; Anke Schumann; Anne-Christine Selbitz; Waltraut Merz; Andrea Gieselmann; Ute Spiekerkoetter
Journal:  JIMD Rep       Date:  2022-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.